Odey Asset Management Group LTD Regeneron Pharmaceuticals, Inc. Transaction History

Odey Asset Management Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $3.8 Million - $4.7 Million	-7,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $491,403 - $603,020	-1,100 Reduced 13.58%	7,000 $3.31 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $932,685 - $1.19 Million	1,950 Added 31.71%	8,100 $3.91 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $2.07 Million - $3.04 Million	6,150 New	6,150 $3 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $1.39 Million - $1.62 Million	-5,100 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $1.15 Million - $1.36 Million	-3,100 Reduced 37.8%	5,100 $2.09 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $618,435 - $749,663	2,173 Added 36.05%	8,200 $2.83 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $157,797 - $206,778	-440 Reduced 6.8%	6,027 $2.27 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $2.79 Million - $3.26 Million	6,467	6,467 $2.89 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Odey Asset Management Group LTD, based on Form 13F filings with the SEC.

Stay updated on Odey Asset Management Group LTD with notifications on news.